TGen News & Press Releases : TGen team links gene to children with physical and intellectual disabilities

TGen News & Press Releases

TGen-Ethos study underscores need for setting high standards in veterinary cancer diagnostics

Posted Tuesday May 21, 2019

Rapid, accurate cancer test is critical for dogs’ treatment and survival

Trends Charitable Fund names TGen beneficiary, supporting women’s and children’s research

Posted Wednesday May 15, 2019

‘Evening of Trends 2019,’ gala set for Nov. 1 at Omni Scottsdale Resort & Spa at Montelucia

Aethlon Medical collaborates with Prostate On-Site Project, host of the Jerry Colangelo Sports Legend Golf Classic, to engage with participants for CTE studies

Posted Monday May 13, 2019

Company also announces European patent covering TAUSOME technology

TGen and HonorHealth contribute to Nature study, discovering possible new treatment and early detection approaches

Posted Wednesday April 17, 2019

Study uncovers role of key protein: Leukemia Inhibitory Factor (LIF)

2019 Fitness for the Cure supports TGen cancer research

Posted Monday April 8, 2019

Non-members welcome to participate April 28 at all four Village Health Clubs in Phoenix, Chandler and Scottsdale

TGen review links gene with the most common liver cancer

Posted Friday April 5, 2019

AKR1B10 could help provide early detection of HCC, and play a role in monitoring and treating this growing cause of cancer death

$6.1 million in grants pave way for TGen-led studies of deadly lung diseases

Posted Wednesday March 27, 2019

50,000 U.S. patients annually diagnosed with Idiopathic Pulmonary Fibrosis

TGen Physician-In-Chief receives Distinguished Public Service Award from AACR

Posted Tuesday March 26, 2019

Dr. Daniel Von Hoff recognized for ‘extraordinary clinical research career’

As if by magic: TGen develops program that lights up cancer-causing mutations

Posted Wednesday March 20, 2019

LumosVar — a name inspired by Harry Potter — could help physicians provide genomic-based treatments for their patients

TGen and ABL pursue global rollout of advanced TB test

Posted Monday March 18, 2019

Licensing agreement puts DeepChek®-TB one step closer to clinical application

Prev
1
[2]
3
4
5
Next

Search

Media Contact

Steve Yozwiak
[email protected]
602-343-8704

Newsletter

News Archive

View Media Release Archive